Posterior arthroscopic treatment of posterior located osteochondral defects of the talus: A long-term follow up study.

Completed

• Conditions: 10005944; cartilage defects; osteochondral defects; 10023213

• Registration Number: NL-OMON42318
• Lead Sponsor: Orthopedie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 40

Inclusion Criteria

- Patients that were treated for an osteochondral defect of the talus by means of 2-portal hindfoot approach in the AMC from 1988 until 2012
- Capable of filling out a questionnaire
- Signed informed consent

Exclusion Criteria

- Systemic disease (e.g. rheumatoid arthritis, lupus erythematosus)
- Ankle trauma 6 months or less prior to follow-up
- Painful or invalid disorder of the lower extremity
- Inability to understand the patient information and the questionnaires (e.g. mental retardation, language barrier)
- No informed consent

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The goal of this study is to evaluate the treatment. The primary outcome<br /><br>measure is the subjective outcome of the patients, measured by the Berndt &<br /><br>Harty Outcome score, and the Ogilvie-Harris score. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcome measures are the VAS pain score at rest, during walking, and<br /><br>during running, the AOFAS score, the SF-36, the Berndt & Harty classification<br /><br>of osteochondral defects of the talus and the osteoarthritis classification<br /><br>previously published by Van Dijk et al.</p><br>